ID
DGX icon

Integral Derivatives’s Quest Diagnostics DGX Stock Holding History

Integral Derivatives’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,800
Closed -$655K – 1404
2014
Q3 		$655K Buy
10,800
+2,900
+37% +$179K 0.01% 870
2014
Q2 		$464K Sell
7,900
-22,100
-74% -$1.29M 0.01% 946
2014
Q1 		$1.74M Buy
+30,000
New +$1.61M 0.03% 466

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Integral Derivatives's DGX Position: Q4 2017 in Review

Integral Derivatives sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 5,800 shares — an estimated $543K sold.

Integral Derivatives first reported a position in DGX in Q4 2013 and held it in 4 quarters. The position peaked at $559K in Q2 2014. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Integral Derivatives reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Integral Derivatives sold 5,800 Quest Diagnostics shares in Q4 2017, an estimated $543K.
  • Integral Derivatives first reported a position in Quest Diagnostics in Q4 2013 and held it in 4 quarters.
  • Integral Derivatives's Quest Diagnostics position peaked at $559K in Q2 2014.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.